New Obesity Drug Now Available Eisai and Arena Pharmaceuticals' obesity drug Belviq is now available in the U.S. Belviq (lorcaserin) is a 5HT2c-receptor agonist that promotes satiety after meals and reduces sensations of hunger before meals.